Vale Professor Jim Denham OAM, TROG founder and world-class researcher

by Biotech Newsroom


9 April 2026

TROG Cancer Research honours the life and legacy of Radiation Oncologist Professor Jim Denham OAM, a founding member and pioneering researcher whose contributions have been central to the organisation’s more than 35-year history.

Jim passed away in March 2026 at the age of 75, leaving a remarkable legacy across cancer care, research and advocacy.

A leading figure in prostate cancer research, he served as a conjoint professor with the University of Newcastle for nearly three decades and as a senior staff specialist…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC